The head of Europe’s pharmaceutical industry body has threatened “a series of lawsuits” in case the European Medicines Agency (EMA) will go ahead with plans to publish more of the clinical trial information it holds, AllTrials campaigners says.
Particularly, the debate is whether the regulatory body should release Clinical Study Reports (CSRs) after the drug has been approved. Pharma argues that this will damage industrial secrets or threat patients privacy.
But researchers at Germany’s medicines licensing body this week showed that these CSRs contain vital information about drug effectiveness and safety – says AllTrials. The regulators and doctors need that information to make decisions about treatments.
I have sent a letter myself to the EMA to push for a more accessible database of trials and data to the availability of researchers, doctors and patients.
Scienceplug fully support AllTrials, and has discussed before why disclosing such information matter.
I am helping AllTrials to look for 10 people to sign the petition, today. Follow the link or push the bottom on the banner of the webpage.
Let’s keep the momentum for real #opendata going, in spite big companies business.